Stories

Harvard innovation—in medicine, technology, education, and beyond—has made Americans' lives easier, healthier, and safer for nearly 400 years.

Harvard research across multiple fronts seeks to expand the impact of a cancer therapy that has left patients and doctors awestruck.

Harvard researchers hope to harness the cognitive benefits of a workout for Alzheimer’s patients with mobility issues.

Across the University, Harvard students, scholars, and faculty turn ideas into ventures that solve problems and create value.

Funded through the President’s Building Bridges Fund, four Harvard student groups launched projects this spring to engage fellow students in meaningful conversations on challenging topics and create frameworks for productive discussions.

Sylvia Mathews Burwell AB ’87 has been elected president of the Harvard Board of Overseers for the 2025–2026 academic year. Monica Bharel MPH ’12 will serve as vice chair of the board’s executive committee for the same term.

A team of Harvard physicists cooled a system made of neutral atoms down a record hundred billion times below room temperature, creating what Faculty of Arts and Sciences professor Markus Greiner calls “the most pristine artificial quantum system ever.” In so doing, the researchers have made it possible to simulate materials in ways that normal computers can’t.

Thousands of alumni from around the world gathered on campus Friday for Harvard Alumni Day — an annual event celebrating alumni of all Harvard Schools and class years and the collective strength of their communities.

Doug Melton’s life irrevocably changed the day his son was diagnosed with Type 1 diabetes. Now, more than 30 years later, the Harvard molecular biologist and his colleagues are within sight of a new treatment that uses stem cells to make healthy insulin-producing cells that can be transplanted into patients.

The virtual quiz game Tango, developed at Harvard, pairs Democrats and Republicans on common teams, where bipartisanship quickly emerges as a competitive advantage. The results showed decreased negative partisanship, increased warmth, and even financial generosity between U.S. players from opposing parties.

Technologies developed by Harvard's David Liu have led to two remarkable medical breakthroughs: a personalized treatment that saved a baby with a fatal genetic disorder and the first successful application of prime editing for a rare immune disease.

Kannon K. Shanmugam AB ’93, JD ’98, a prominent and prolific appellate attorney, will join the Harvard Corporation as its newest member. He will succeed Theodore V. Wells Jr. JD ’76, MBA ’76, who departs the board after 12 years of service.

A firefighter-paramedic before coming to Harvard Kennedy School, Rupen Dajee MPA '25 started a technology venture that develops tools to help solve some of the challenges facing wildland firefighting, emergency services, and disaster management.

In a video interview with NPR's Morning Edition, President Alan Garber said institutions need to double down on their "commitment to the good of the nation" and be firm in what they stand for.

President Alan Garber sat down with the Harvard Gazette to reflect on the challenges of a turbulent year and the promise of Commencement.

Six alumni have been elected to the University’s Board of Overseers and another six to the board of directors of the Harvard Alumni Association. 

With support from Harvard’s Bok Center for Teaching and Learning, graduate student teachers make classrooms a place for open inquiry and constructive dialogue.

Incoming Harvard Alumni Association board president William Makris EdM '00 hopes alumni will share experiences and learn from one another.

Ultan McCaffrey MPH ’25 has been able to combine his interest in space medicine with his work in geriatric psychiatry in Harvard Chan School’s MPH-GEN program.

GLP-1 has transformed the treatment of obesity, diabetes, and cardiometabolic disorders that affect more than a billion people worldwide. But when Harvard researcher Joel Habener set up an experiment that helped lead to the discovery of the hormone more than three decades ago, this outcome was far from clear.